1. Home
  2. MTEK vs MBIO Comparison

MTEK vs MBIO Comparison

Compare MTEK & MBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Maris-Tech Ltd.

MTEK

Maris-Tech Ltd.

HOLD

Current Price

$0.42

Market Cap

4.1M

Sector

N/A

ML Signal

HOLD

MBIO

Mustang Bio Inc.

N/A

Current Price

$0.37

Market Cap

4.1M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
MTEK
MBIO
Founded
2008
2015
Country
Israel
United States
Employees
16
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.1M
4.1M
IPO Year
2021
2023

Fundamental Metrics

Financial Performance
Metric
MTEK
MBIO
Price
$0.42
$0.37
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
★ 511.9K
36.3K
Earning Date
09-02-2026
11-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 98.99
EPS
★ N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$405.45
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.37
$0.37
52 Week High
$2.82
$1.52

Technical Indicators

Market Signals
Indicator
MTEK
MBIO
Relative Strength Index (RSI) 26.16 29.78
Support Level N/A N/A
Resistance Level $1.12 $0.56
Average True Range (ATR) 0.05 0.03
MACD -0.00 -0.00
Stochastic Oscillator 14.87 10.84

Price Performance

Historical Comparison
MTEK
MBIO

About MTEK Maris-Tech Ltd.

Maris Tech Ltd is a B2B provider of intelligent video transmission technology with AI acceleration for edge platforms, using high-end digital video, audio, and wireless communication technologies. It designs, develops, manufactures, and commercially sells miniature intelligent video and audio surveillance and communication systems with AI acceleration for the professional, civilian, and home security markets. Its products and solutions are sold as off-the-shelf, standalone, and ready-to-use products, or as customized components that meet customers' requirements and integrate into their systems and products. Its customers include companies operating in the drone, robotic, defense, HLS, intelligence gathering, autonomous vehicle, and space markets. It generates maximum revenue from Israel.

About MBIO Mustang Bio Inc.

Mustang Bio Inc is a clinical-stage biopharmaceutical company focused on translating today's medical breakthroughs into potential cures for difficult-to-treat cancers. It acquires rights to these technologies by licensing or otherwise acquiring an ownership interest in the technologies, funding their research and development, and eventually either out-licensing or bringing the technologies to market. Its pipeline is currently focused on the core areas of gene therapies for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (CAR T) therapies for hematologic malignancies, and CAR T therapies for solid tumors.

Share on Social Networks: